Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Video
  • Podcasts
  • Write for us
  • News for You
  • Covid-19
  • Video
  • Podcasts

Search Results for azd1222

Pakistan Authorizes AZD1222 (AstraZeneca) for Emergency Use While SinoPharm is Next; Ad5nCoV in Phase 3 Trial

Pakistan authorized the use of the AstraZeneca COVID-19 vaccine recently. Approved for emergency use, the vaccine originally developed at University of […]

Pakistan Authorizes AZD1222 (AstraZeneca) for Emergency Use While SinoPharm is Next; Ad5nCoV in Phase 3 Trial
1 week ago
Share
0

KEMRI-led Investigation into AZD1222 (Oxford Vaccine) Commenced with First Vaccinations in Kenya

The AstraZeneca COVID-19 vaccine trial, investigating the safety and efficacy of the “Oxford” vaccine now known as AZD1222, has come […]

KEMRI-led Investigation into AZD1222 (Oxford Vaccine) Commenced with First Vaccinations in Kenya
2 months ago
Share
0

Oxford University & WHO Experts Suggest more Data Needed to Properly Assess AZD1222 (AstraZeneca Vaccine)

Recently, experts from Oxford University and the World Health Organization (WHO) shared that additional data would be required about AZD1222, […]

Oxford University & WHO Experts Suggest more Data Needed to Properly Assess AZD1222 (AstraZeneca Vaccine)
2 months ago
Share
1

Is Confidence in AZD1222 Waning Among the Drug Development Community?

The world has placed high hopes on the COVID-19 vaccine candidate originally developed in Oxford (ChAdOx1 nCoV-19) and now licensed […]

Is Confidence in AZD1222 Waning Among the Drug Development Community
2 months ago
Share
0

Small Tribe in Pacific Northwest Drop AZD1222 & Seek Participation in Novavax COVID-19 Vaccine Clinical Trial

What does a niche vaccine-focused biotech from Gaithersburg, MD toiling in relative obscurity for years and a small Native American […]

Small Tribe in Pacific Northwest Drop AstraZeneca & Seek Participation in Novavax COVID-19 Vaccine Clinical Trial
3 months ago
Share
1

University of Vermont Medical Center Ramps Up Phase 3 Trial Investigating AZD1222 COVID-19 Vaccine Candidate: Seeking Volunteers

The University of Vermont Medical Center was selected as a trial site location by AstraZeneca for the Phase COVID-19 clinical […]

University of Vermont Medical Center Ramps Up Phase 3 Trial Investigating AZD1222 COVID-19 Vaccine Candidate Seeking Volunteers
3 months ago
Share
0

UW-Madison Moves Forward with COVID-19 Vaccine (AZD1222) Clinical Trial After Several Week Pause

Although TrialSite reported yesterday that both the AstraZeneca and the Johnson & Johnson vaccine trials received the U.S. Food and Drug […]

UW-Madison Moves Forward with COVID-19 Vaccine (AZD1222) Clinical Trial After Several Week Pause
3 months ago
Share
0

Volunteer in the AstraZeneca AZD1222 Clinical Trial Dies in Brazil, However, Reports are Death Not Connected to Oxford Vaccine: Trial Apparently to Proceed

Shares of AstraZeneca’s stock declined as a volunteer participating in the Phase 3 clinical trial in Brazil died, reports Brazil’s […]

Volunteer in the AstraZeneca AZD1222 Clinical Trial Dies in Brazil, However, Reports are Death Not Connected to Oxford Vaccine: Trial Apparently to Proceed
3 months ago
Share
0

Indonesia Secures Deal with AstraZeneca for 100 Million Doses of AZD1222 to Fight COVID-19

The nation of Indonesia, the fourth most populous worldwide, has inked a deal with AstraZeneca to buy 100 million COVID-19 […]

Indonesia Secures Deal with AstraZeneca for 100 Million Doses of AZD1222 to Fight COVID-19
3 months ago
Share
0

European Medicines Agency Initiates Rolling Review of AZD1222 While FDA Puts Trial on Hold for a Different Review

The European Medicines Agency (EMA) human medicines committee (CHMP) reports publicly the first ‘rolling review’ of a COVID-19 vaccine starting […]

European Medicines Agency Initiates Rolling Review of AZD1222 While FDA Puts Trial on Hold for a Different Review
4 months ago
Share
0

Posts navigation

Older posts

Trending News

  • Not Using Ivermectin, One Year In, Is Unethical And Immoral
    Not Using Ivermectin, One Year In, Is Unethical And Immoral
  • New York Supreme Court Judge Order: Give The Patient Ivermectin As Court Battle Leads to Ivermectin for Successful Treatment Against COVID-19
    New York Supreme Court Judge Order: Give The Patient Ivermectin As Court Battle Leads to Ivermectin for Successful Treatment Against COVID-19
  • An Unlikely Nation Is Kicking This Pandemic. Guess Which. Then Why.
    An Unlikely Nation Is Kicking This Pandemic. Guess Which. Then Why.
  • Oxford’s Principal Trial: Bringing Ivermectin Directly into the Developed World in the Battle Against COVID-19
    Oxford’s PRINCIPLE Trial: Bringing Ivermectin Directly into the Developed World in the Battle Against COVID-19
  • Unitaid, Part of the World Health Organization Funding Ivermectin Research Targeting COVID-19 led by British Expert
    Unitaid, Part of the World Health Organization Funding Ivermectin Research Targeting COVID-19 led by British Expert

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.